Bayer succeeds in upholding ciprobay patent in Canada
Bayer succeeded in its battle to uphold the patent on its anti-anthrax treatment ciprobay in Canada and said it agreed to supply one of the Canadian government in the next 48 hours.
Bayer succeeded in its battle to uphold the patent on its anti-anthrax treatment ciprobay in Canada and said it agreed to supply one of the Canadian government in the next 48 hours.